Calpeptin treatment decreases cell density and proliferation. by Daniela M. Santos (211055)

<i>In vivo</i> treatment with 17-AAG decreases <i>L. (V.) braziliensis</i> infection. by Diego M. Santos (111145)

Sphere-forming efficiency decreases following radiation. by Vicky T. Nguyen (5029244)

PTPN12 decreases neurite-like outgrowth in TrkB-SH-SY5Y cells. by Malene Ambjørn (421718)

Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

Demonstration of the effects of decreased size at metamorphosis on amphibians by Tyrone B. Hayes (29098)

Increased sorting endosome size and decreased EHD1 recruitment upon Rabenosyn-5 knock-down. by Tyler Jones (4507858)

Chronic RAS blockade decreases oxidative stress. by Lai Ming Yung (353970)

Hsp90 depletion decreases stress resistance. by Michelle D. Leach (108675)

Estimation the degree of essentialized human qualities (average of the five qualities) for each of the 16 individual robots, presented as a function of the degree of human resembla... by Tatjana A. Nazir (12262825)

MiR-29b-2-5p is decreased upon <i>Shigella</i> infection. by Ushasree Sunkavalli (3916721)

Increase of mitochondrial dysfunction and glycolysis by decreased NEFH. by Myoung Sook Kim (91321)

SARS-CoV‑2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity by Mert Golcuk (10789806)

SARS-CoV‑2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity by Mert Golcuk (10789806)

TPP decreases melanoma tumor growth rate when administered via hydrogel. by Kyle C. Kloepping (9928265)

Deletion of the <i>aspC</i> gene decreases the number of origins per cell and the decrease is reversed by extra AspC. by Feng Liu (72874)

Tranilast decreases RANKL-induced ROS level. by Tien Van Phan (583324)

Protein degradation via the ubiquitin proteasome activity decreases with age and castration tends to increase the activity of this system. by Arik Davidyan (10450896)

Increased oxidative stress, viral load and decreased survivability of N2a following RIG-I ablation. by Arshed Nazmi (215284)

“…<p>Flow cytometric analysis carried out from cells of all treatment groups to detect intracellular JEV antigen showed significant increase post RIG-I ablation when compared to only JEV-infected or JEV+ScMO groups. The mean fluorescence intensities obtained from each group are depicted in the figure. (1-Unstained, 2-Mock-infected; 3-JEV-infected, 4-JEV+Sc-MO, 5-JEV+rMO) (A). …”

Cell growth and viability decrease confirmed by growth inhibition in HepG3. by Arlet Hernandez (12289155)